IGF1 and metabolic dysfunction-associated steatotic liver disease: Decreased hepatic synthesis function and portal shunt in NAFLD could reduce IGF-1 levels (41), which further decreases osteoblast activity and leads to a bone resorption ratio greater than bone synthesis, thus promoting the development of OP.